BeiGene Selects GE Healthcare’s Off-the-Shelf Biologics Factory to Boost its Manufacturing Capacity for Cancer Drugs

  BeiGene to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies  CHALFONT ST. GILES, UK and BEIJING, CHINA – 18 September 2018 – BeiGene, Ltd., a commercial

https://www.ge.com/news/press-releases/beigene-selects-ge-healthcares-shelf-biologics-factory-boost-its-manufacturing